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Background: Upon co-stimulation with CD3/CD28 antibodies, activated CD4 + T cells were found to lose their
susceptibility to HIV-1 infection, exhibiting an induced resistant phenotype. This rather unexpected phenomenon
has been repeatedly confirmed but the underlying cell and molecular mechanisms are still unknown.
Methods: We first replicated the reported system using the specified Dynal beads with PHA/IL-2-stimulated and
un-stimulated cells as controls. Genome-wide expression and analysis were then performed by using Agilent whole
genome microarrays and established bioinformatics tools.
Results: We showed that following CD3/CD28 co-stimulation, a homogeneous population emerged with uniform
expression of activation markers CD25 and CD69 as well as a memory marker CD45RO at high levels. These cells
differentially expressed 7,824 genes when compared with the controls on microarrays. Series-Cluster analysis
identified 6 distinct expression profiles containing 1,345 genes as the representative signatures in the permissive
and resistant cells. Of them, 245 (101 potentially permissive and 144 potentially resistant) were significant in gene
ontology categories related to immune response, cell adhesion and metabolism. Co-expression networks analysis
identified 137 “key regulatory” genes (84 potentially permissive and 53 potentially resistant), holding hub positions
in the gene interactions. By mapping these genes on KEGG pathways, the predominance of actin cytoskeleton
functions, proteasomes, and cell cycle arrest in induced resistance emerged. We also revealed an entire set of
previously unreported novel genes for further mining and functional validation.
Conclusions: This initial microarray study will stimulate renewed interest in exploring this system and open new
avenues for research into HIV-1 susceptibility and its reversal in target cells, serving as a foundation for the
development of novel therapeutic and clinical treatments.
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A comprehensive picture of the host factors putatively
supporting HIV-1 (human immunodeficiency virus, type
1) replication in cells has emerged from recent siRNA
studies [1-4] and meta-analysis [5]. Genome-wide land-
scapes of host genes and proteins involved in HIV-1 infec-
tion and disease progression have also been established in
gene array studies [6-9] and novel proteomic approaches
[10-12]. In parallel, genome-wide association studies
(GWAS) have revealed a set of inheritable genetic varia-
tions in large populations related to susceptibility to HIV-
1 infection [13-15].
Against these exciting developments, there is still no
global view of the host cellular factors that render the
target cells resistance to infection, in spite of a few well-
studied restriction factors [16-19]. A recent genome-
wide screening for novel restriction factors [20] further
highlighted this awareness and our interest in establishing
a more holistic pictures of the host determinants working
against HIV-1 susceptibility.
A crucial starting point for studies of this type is the
consideration of sample sources, cell types, and experi-
mental settings. In this regard, CD4 + T cells are the first
choice; they are the major cell type amongst all the sus-
ceptible targets and reservoirs of HIV-1 infection [21].
Apart from their intrinsic susceptibility, CD4 + T cells’ ac-
tivation in vivo (during the natural courses of HIV-1 infec-
tion) and in vitro (typically with PHA/IL-2 stimulation) is
generally recognized as an absolute prerequisite for the
virus to replicate productively [22]. However, rather unex-
pectedly, Levine et al. (1996) found that activation by co-
stimulation with CD28 led to a complete loss of suscepti-
bility to HIV-1 infection in these cells. This phenomenon
was subsequently confirmed by several independent
groups [23-26]. In spite of the fact that several further
studies attempted to explore the potential of using thus-
stimulated cells for the treatment of SIV/HIV infection in
monkey models and clinical settings, progress in elucidat-
ing the underlying cellular and molecular mechanisms
seems to have halted since 2002 for unknown reasons.
In the present study, in order to investigate the pos-
sible mechanisms of the observed reversal of HIV-1
susceptibility in these activated CD4 + T cells, we first
replicated the reported experimental settings [27] and
then performed genome-wide expression analysis using
Agilent microarrays.
Methods
Isolation and stimulation of CD4+ T cells
Buffy coats were obtained from healthy donors (Kunming
Blood Station) and peripheral blood mononuclear cells
(PBMCs) were isolated by Ficool-Hypaque (TBD Sciences)
gradient centrifugation. Resting CD4 + T cells were then
purified by magnetic negative selection (CD4 + T cellIsolation Kit II, Miltenyi Biotec) and only the aliquots of
cells with purity > 95% as determined by flow cytometry
were used for further analysis. This study was reviewed
and approved by the internal review board of the Kunming
Institute of Zoology, Chinese Academy of Sciences (ap-
proval ID: RTYX20090910-1, approval date: 2009-09-10).
All donors provided written informed consent for partici-
pation in this study.
Cells were stimulated as previously reported [27,28].
Briefly, freshly isolated CD4 + T cells were resuspended
in RPMI 1640 medium (Gibco) supplemented with 10%
heat inactivated fetal bovine serum (Gibco) and 20 mM
HEPES (Amresco) and seeded in 6-well plates either at
an initial density of 2 × 106 cells/well with human recom-
binant IL-2 (100 U/ml) and PHA (5 μg/ml) or 0.5 × 106
cells/well with polystyrene beads coated anti-CD3/CD28
antibodies (Dynal beads CD3/CD28 T Cell Expander,
Dynal) at a bead to cell ratio of 3:1. Half media were
changed every 2 days in CD3/CD28 costimualted CD4 +T
cells and every 3 days in PHA/IL-2 stimulated cells. Cells
were then cultured at 37°C in a humidified incubator with
5% CO2 for 6 days. Cells and the derived RNA samples
and data sets were labeled “P”, “R”, and “B”, respectively,
according to the PHA/IL-2 stimulated, un-stimulated rest-
ing and beads-stimulated settings.Flow cytometry
Aliquots of cells to be analyzed were washed with FACS
buffer (PBS supplemented with 1% bovine serum albumin
(BSA)) and stained for 40 minutes in the dark at 4°C
with anti-CD45RO-FITC, anti-CD25-PE, anti-CXCR4,
fluorescent dye 5-(and −6)-carboxyfluorescein diacetate
succinimidyl ester (CFSE) (Sigma-Aldrich), anti-Ki67
(Abcam), anti-CCR5 (Biolegend) and anti-CD69-PE-Cy-
5 (BD Biosciences) and appropriate isotype controls.
After washing with FACS (Fluorescence Activated Cell
Sorter) buffer, cells were fixed with 4% paraformalde-
hyde and analyzed on a FACS Calibur using Cell Quest
and FlowJo 7.6.1.Gene expression profiling with Agilent microarrays
Total RNA was extracted from stimulated or un-stimulated
CD4 +T cells by TRIzol (Invitrogen) followed by a purifica-
tion using RNeasy columns (Qiagen) according to the man-
ufacturer’s protocols. The amount and quality of RNA
preparations were evaluated on an Agilent 2100 Bioanalyzer
with RNA6000 Nano Reagents and Supplies (Agilent).
Quality-checked RNAs were then transcribed with the
First-Strand cDNA Synthesis Kit (Agilent) and their
expression data obtained using Agilent 4 × 44 K Human
Whole-Genome 60-mer oligonucleotide microarrays
according to the protocols by the manufacturer. The ori-
ginal microarray data from this study are available at the
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under the accession number GSE34252.
Analysis of microarray data
The normalized ratio of the gene expression signals was
log2 transformed and hierarchical clustering was per-
formed with average linkage. The clustered heatmap
was visualized using Treeview. The RVM (Random vari-
ance model) f-test was applied to filter differentially
expressed genes for the different situations. After the
significance analysis and FDR (false discovery rate)
analysis, we selected the differentially expressed genes
according to the p-value and FDR threshold set at p <
0.01 and FDR <0.01 [29-31]. And the fold changes of
any two groups are more than 2.
Series-Cluster analysis was performed to identify the
global trends and model profiles of expression according
to signal density under the “P”, “R” and “B” conditions
and in the P-R-B sequence. Fisher’s exact test and the
multiple comparison test [32,33] were applied to identify
the model profiles with probability significantly higher
than expected as random.
Gene ontology (GO) analysis [34] was performed to fa-
cilitate elucidating the biological implications of unique
genes in the significant or representative profiles. GO
analysis was used to find the main function of the genes
having the same expression trend according to the Gene
Ontology. Fisher’s exact test and χ2 test were applied to
identify the significant GO categories and FDR was used
to correct the p-values.
Gene co-expression networks analysis [35] were per-
formed to track the interactions among the differentially
expressed genes, according to their normalized signal in-
tensity in 6 representative profiles. Pearson correlation
was applied to each pair of genes and the significantly
correlated pairs were used to construct the network [36].
To locate the core regulatory genes in the networks, k-
core scoring was introduced to simplify graph topology
analysis [37,38]. A k-core of a given gene indicates its
hub or nodal status with connection to “k” other genes
in a network [37,38]. Accordingly, the genes with largest
k-core scores and highest degrees of connection were
identified as “key regulatory genes” in a network [39]
and those unique to each network were selected as
“marker genes” for the cellular status of intrinsic suscep-
tibility or induced resistance to HIV-1 infection.
Results
Cellular characterization of stimulated and un-stimulated
CD4+ T cells
Following the previously published details of the initial
experiment (Levine et al. 1996) and other independent
studies [23-26], we re-established de novo and verified
the experimental systems (Figure 1). After stimulationfor 6 days with the CD3/CD28 antibodies coated beads
(labeled “B” for beads), purified CD4 + T cells became en-
larged and highly proliferative, forming a large amount of
big cell colonies (Figure 1A). When compared with the
un-stimulated (labeled “R” for resting) or PHA/IL-2-stim-
ulated (labeled “P” for PHA) cells at the functional level,
the induced resistance to HIV-1 infection in these co-
stimulated cells [23-28] was also readily replicated in our
earlier experiments (described as a brief report in a home
journal [40]). We monitored the cell viability and prolifer-
ation first by Trypan blue exclusion test which showed
more than 95% viable cells for all the experiments (data
not shown) and then by Ki67 and CFSE staining
(Additional file 1: Figure S1 and Additional file 2: Figure
S2). We then proceeded to analyze the surface phenotypes
of the generated cells and found that a homogeneous
population of cells emerged following the co-stimulation
(Figure 1B). In contrast to the controls, these cells were
uniformly and simultaneously stained positive for both the
general and early activation markers (CD25 and CD69, re-
spectively) at high levels (Figure 1B). Another important
marker for activated and memory T cells, CD45RO, was
also uniformly expressed following co-stimulation in these
“B” cells but in a much lower percentage than in “R” or
“P” cells (Figure 1B).
Global expression profiles and signatures
Using Agilent 4 × 44 K Human Whole-Genome Micro-
arrays, we found that the overall gene expression pat-
terns were clearly and sharply different among the “R”,
“P” and “B” cells. As shown in Figure 2 (left) with their
clustered heatmaps and hierarchical patterns, in total
7,824 genes represented 8,128 transcripts (out of the
41,000 test probes on the chips) were differentially
expressed according to the RVM (Random variance
model) algorithm (p-value < 0.05, FDR < 0.05) (Additional
file 3: Table S1).
In subsequent Series-Cluster analysis, we identified 16
possible profiles (Figure 2 middle) (Additional file 4:
Table S2), which represent the overall expression pat-
terns. Of these, 10 (#1, 5, 6, 7, 8, 9, 10, 11, 12 and 15,
Figure 2 middle) showed the sharp difference between “B”
and “P” cells. More specifically, genes down-regulated in
“P” cells are shown in the “Pdown” (#1) profile and those
up-regulated in these cells were grouped in the “Pup” (#9)
profile (Figure 2 right). Similarly, genes up- or down-
regulated only in “B” are represented in “Bup” (#8) and
“Bdown” (#15) profiles. We merged three profiles (#5, 6
and 7) that contain the genes down-regulated in “P” but
up-regulated in “B” into a new “PdownBup” profile, in order
to show their special importance in the reduced resistance
as they contain the genes which were down regulated in
the susceptible “P” cells and at the same up-regulated in
the resistant “B” cells. In the same way, we merged profiles
Figure 1 Morphology and surface phenotypes of stimulated and un-stimulated CD4+ T cells. A: CD4 + T cells stimulated with PHA/IL-2
(“P”) or CD3/CD28 coated beads (“B”) were observed on day 0 (un-stimulated (“R”)), day 3 and day 6. B: Flow cytometric analysis of cell surface
phenotypes. “R”, “P” and “B” cells were stained with antibodies to CD25 (FITC), CD69 (PE-Cy5) and CD45RO (FITC). Numbers indicate the
percentage of each subset. A majority population of cells emerged in “B” cells which expressed CD25, CD69 and CD45RO. We did the
experiments in 19 biological replicates.
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genes that were up-regulated in “P” cells but at the same
time down-regulated in the “B” cells (Figure 2 right).
These 6 representative profiles contain 1,345 differentially
expressed genes in “B” and “P” cells (Figure 3 left) and give
the apparent expression signatures either unique to “P” and
“B” cells or polarized expressed in “P” and “B” cells at two
opposite extremities. The remaining 6,479 genes differen-
tially expressed in the other 6 profiles (#2, 3, 4, 13, 14 and
16, Figure 2 middle) were unique to the “R” cells, up- or
down-regulated when compared with “P” and “B” cells as
the baseline. Due to the nature of the “R” cells that are
seemingly susceptive to the infection but do not support
active viral replication, the biological importance of thesegenes in HIV-1 infection are more complicated to dissect
and interpret. We kept aside these 6,479 “R” cell-unique
genes for future studies.
Functional categories and significant ontologies of the
differentially expressed genes in “P” and “B” cells
It is immediately noticeable (Figure 3 left) that most of the
1,345 differentially expressed genes in the 6 representative
profiles falls in the “B” cell-related expression, with 471
genes in the “Bdown” profile and 465 in “Bup”, respectively,
representing the down-regulated and up-regulated un-
permissive genes in the resistant “B” cells (Figure 3 left,
Additional file 5: Table S3). In the “Bdown” profile, 222 genes
with known functions gave a rather complicated ontology
Figure 2 Overall patterns of 7,824 differentially expressed genes and the 6 representative profiles in the permissive “P” and resistant
“B” cells. Patters were plotted on the heatmap using Treeview. Red represents up-regulated genes while green represents down-regulated
genes. Hierarchical clustering is shown on the left. All 16 expression profiles identified by Series-Cluster analysis are shown in the middle and 6
summarized representative profiles are shown on the right.
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FDR analysis, a clearer picture emerged. Statistically, 43
genes were significantly involved in 4 major functional
categories (Figure 3 middle), showing: (a) response to
stimulus (immune response, cell surface receptor linked
signal transduction and positive regulation of natural killer
cell mediated cytotoxicity); (b) metabolic process; (c)
multicellular organismal development; and (d) cellularprocess are predominantly influenced by the co-
stimulation.
Other part of exactly the same 4 major categories was
found significantly influenced in the “Pup” and “PupBdown”
profiles, with part of one more category (localization) being
also up-regulated in the permissive “P” cells or down-
regulated in the un-permissive “B” cells (Figure 3 middle).
Combined GO analysis of the genes in the “Pup”, “PupBdown”
Figure 3 Gene ontology (GO) analysis and significant functional genes. Left: Numbers of genes in the 6 representative profiles. Middle:
significant functional categories and the number of genes in them. Each color represents one category and the size of each sector in a pie
diagram is proportional to the number of genes in its category. Right: Merged functional categories in permissive “Pup”, “Bdown” and “PupBdown”
cells and resistant “Pdown”, “Bup” and “PdownBup” cells.
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eration) was also significantly influenced (Figure 3 right).
Altogether, these 6 significantly affected functional categor-
ies contain 101 genes (Figure 3 right) representing the
whole set of the “permissive genes” that are associated posi-
tively with the highly susceptible status or negatively with
the induced resistance of the cells. As shown in Figure 4A,
these permissive genes are clearly hierarchical and highly
enriched in the categories related to defense, immune/in-
flammatory response and signal transduction under the
general heading of response to stimuli [41].
More genes (352) with known functions were identified
in the “Bup” profile with 117 being significantly involved
in 7 major GO categories, showing that (a) cellular process
(cell adhesion, cell differentiation and regulation of tran-
scription), (b) multicellular organismal development, (c)
metabolic process, (d) response to stimulus, (e) localization,
(f) circulatory system process, and (g) others are predomin-
antly up-regulated following the co-stimulations. Exactly
the same 7 categories were also up-regulated in the
“PdownBup” profile, although the numbers of the genes in
each category varied (Figure 3 middle right). These 7 cat-
egories contain all the 4 significant ones in the “Pdown”Figure 4 Hierarchical GO categories of genes involved in induced per
hierarchically built using the Gene Ontology Enrichment Analysis Software Too
of response to stimulus related genes in “Pup”, “Bdown” and “PupBdown” cells is sh
process and metabolic process related genes in “Pdown”, “Bup” and “PdownBup” cprofile and one more category (cell fate determination) was
also identified. Altogether, the 8 categories contain 144
genes representing the whole set of the “resistant genes”
that are associated positively with the induced resistance or
negatively with the highly susceptible status of the cells
(Figure 3 right). However, they are dispersed in more
diverse categories (Figure 4B) than the permissive ones
(Figure 4A), indicating that the resistant genes have wider
influence in cellular functions and may hold the crucial
check points for HIV-1 infection in “multicellular organis-
mal development”, “cellular process” and “metabolic
process”. One of the striking examples is that 30 genes
involved in the process of cell adhesion were found up-
regulated in “B” cells (profiles “Bup” and “PdownBup”)
(Figure 4B) (Additional file 6: Table S4).
Direct interactions of the genes with known functions
with HIV-1 proteins
When subjected to further screening, 22 of the 144 po-
tential “resistant genes” and 23 of the 101 potential
“permissive genes” were identified for their direct inter-
actions with HIV-1 proteins (Figure 5A & Additional file 7:
Table S5), according to the data in the “HIV-1 Humanmissive “P” and resistant “B” cells. GO categories trees were
lkit (GOEAST): http://omicslab.genetics.ac.cn/GOEAST/). The category tree
own in A. Category trees of multicellular organismal development, cellular
ells are shown in B.
Figure 5 (See legend on next page.)
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Figure 5 Interactions of significant functional genes with HIV-1 proteins. Filled circles represent genes involved in significant functional
categories. Red represents genes in profiles “Pdown”, “Bup” and “PdownBup”, while green represents genes in profiles “Pup”, “Bdown” and “PupBdown”.
Unfilled squares represent HIV-1 proteins. A: Overall interactions of significant functional genes with HIV-1 proteins; B: Functional categories of
known gene interaction with HIV-1.
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gov/RefSeq/HIVInteractions/). Their significant functional
categories are shown in Figure 5B.
Specifically, 3 (Env, Nef, and Tat) of HIV-1 proteins
attracted most of the host (no matter permissive or resist-
ant) factors in this set of data, suggesting that host factors
may have the capacity to counterbalance with the permis-
sive genes by interacting with the same early genes in HIV-
1 infection. This is coincided with the initial report that the
novel anti-HIV effect induced by co-stimulation happens
around viral entry and before integration [27]. However, in
terms of host gene functions, no overlap was identified be-
tween the resistant and permissive genes as the former
were mapped on the categories of cell adhesion, multicellu-
lar organismal development and cell differentiation, while
the latter on immune response, cell surface receptor signal
transduction, cellular defense response and chemotaxis.
Fewer but prominent genes, e.g., CD59, IL-2, IL-15, INDO
and FN1 were found to interact with Gag and Vpr, al-
though we did not find any genes in all our profiles capable
of interacting with HIV-1 Vif or Rev.
Co-expressed genes and their networks in the permissive
“P” and un-permissive “B” cells
Given that HIV-1 tends to interact with “key” host pro-
teins, such as bottlenecks and hubs in gene interaction
networks [42,43], we used the genes in the representa-
tive profiles and constructed 6 gene co-expression net-
works (Figure 6 left). We then applied the “k-core”
scores (see Methods) to identify those with highest net-
working degrees as the “key regulatory” genes that may
play pivotal roles in gene interactions and regulations.
Thus, 53 genes in profiles “Pup”, “Bdown” and “PupBdown”,
which tentatively contain the “permissive genes” were
chosen as “key regulatory” genes and, among them, 29
genes with known functions (underlined in Figure 6
middle) are involved in immune response, signal trans-
duction and so on (Figure 6 right). Similarly, 84 genes in
profiles “Pdown”, “Bup” and “PdownBup”, which tentatively
contain the “resistant genes”, stood out with the highest
k-core scores and, out of them, 36 genes (underlined in
Figure 6 middle) are involved in cell adhesion, multicel-
lular organismal development and so on (Figure 6 right).
KEGG pathways and schematic overview of HIV-host gene
interactions in the resistant “B” cells
We then mapped all the genes with known functions in
the significant categories (Figure 3) and all the “keyregulatory” genes (Figure 6) on KEGG pathways from the
Kyoto Encyclopedia of Genes and Genomes database. A
clear picture emerged in the resistant “B” cells showing
(Figure 7) that (a) the up-regulated genes in “Bup” and
“PdownBup” profiles were enriched in the cellular processes
(Figure 8) including: filamentous actin (F-actin), tight
junction, actomyosin assembly contraction, proteasomes,
proteolysis, lysosomes, degradation, and Na+ Ca2+ ex-
change, and (b) the down-regulated genes in “Bdown” and
“PupBdown” profiles were enriched in the process of actin
polymeration, apoptosis, cell cycle checkpoint, ER to Golgi
transport and terminally misfolded.
Verification of the differential gene expression by FACS
We then performed FACS analysis to examine the expres-
sion levels of two HIV-1 co-receptors, CCR5 and CXCR4.
As shown in (Figure 9), CCR5 was up-regulated in the per-
missive “P” cells but down-regulated in the resistant “B”
cells, while CXCR4 remained down-regulated in both “P”
and “B” cells. These data not only validated our microarray
analysis—albeit only a small part of the whole data set—but
also were consistent with the initial findings that the in-
duced resistance was only effective to CCR5-dependent
strains of the HIV-1 virus [24,44,45]. This also confirmed
our previous report [40] showing that, following co-
stimulation, the levels of CCR5 expression varied to some
degrees in the 12 individuals tested, but the general trend
was clearly down-regulated. Conceivably, the down-
regulation of the critical co-receptor CCR5 accounts, at least
in part, for the induced resistance in the co-stimulated cells.
Clues for novels genes accounting for HIV-1 susceptibility
and resistance
It should be noted that the aforementioned co-expression
network analysis was performed using all the genes with
and without known functions. Strikingly, among the total
137 “key regulatory” genes, only 9 genes have been previ-
ously reported to interact with HIV-1 (Table 1) while the
remaining majority (128 genes) as of yet have no confirm-
ation of their potentials to interact with HIV-1 genes or pro-
teins. When going back to the 1,345 differentially expressed
genes in the 6 representative profiles (Figure 2 left), around
a third of them (513 genes) do not yet have any assigned
functions. In view of their prominence in the representative
profiles and co-expression networks, these unknown genes
constitute a new source for future studies on their roles in
biological processes and potential involvement in deter-
mining HIV-1 susceptibility and resistance.
Figure 6 Co-expressed genes and their networks. Left: Number of genes in 6 representative profiles (Figure 3 middle left). Red nodes
represent “key regulatory” genes while blue nodes represent other regulated genes. Node size represents the power of the interrelation among
the nodes, and edges between two nodes represent interactions between genes (i.e. the more edges of a gene, the more genes connecting to
it, the more central role it has within the network). Middle right: Name list of “key regulatory” genes with highest k-core. Green represents
unknown genes; known functional genes were underlined. Right: significant function of these genes.
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Figure 7 Schematic overview of the cellular genes altered in “B” cells. Up: Analysis strategy and results. Down: Schematic network was
constructed by 245 genes involved in significant GOs (Figure 3) and 137 genes in co-expression networks (Figure 6) that can also be mapped on
KEGG pathways. Processes and genes in profiles “Bup” and “Pdown Bup” or “Bdown” and “PupBdown” are respectively represented by red or green
nodes. Purple represents HIV proteins.
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In the present study, we re-established an experimental
system for cellular and molecular studies on the induced
resistance to HIV-1 infection in CD4 +T cells as first
reported by Levine et al. [27]. This cellular system includes
two methods most commonly used to activate and expand
CD4 +T cells in vitro. Incubation with PHA/IL-2 inducesproliferating CD4 +T cells which are highly susceptible to
HIV-1 infection and highly permissive for the subsequent
viral replication, whereas co-stimulation with CD3/CD28
reverses the intrinsic susceptibility in these cells and ren-
ders them with resistance to HIV-1 infection and un-
permissiveness for viral replication. Thus, these two
extremely polarized statuses of activated CD4 +T cells,
Figure 8 Actin cytoskeleton and endoplasmic reticulum associated protein degradation related genes in schematic network. A: Actin
cytoskeleton related genes up-regulated in “B” cells. B: Endoplasmic reticulum associated protein degradation related genes up-regulated in “B” cells.
Figure 9 Verification of CCR5 and CXCR4 expression by flow cytometry. Cells of “R”, “P” and “B” were stained with antibodies to CCR5 (PE)
and CXCR4 (PE) as described in Methods. Numbers indicate the percentage of gated subset that expressed CCR5 or CXCR4. These results have
been replicated and confirmed in 10 individuals.
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fection but not permissive for the rapid viral replication)
as control in the middle of the “spectrum of permissive-
ness”, constitute a highly insightful system in the search
for host factors responsible for HIV-1 susceptibility and
its reversal in CD4 + T cells.
We were attracted more by the biological significance
and potentials of the induced resistance in the “B” cells.
We first replicated this in vitro system and verified its use-
fulness (Figure 1 and [40]) at the cellular level. Considering
the controversy around the source cells, i.e., which subsets
(naïve or memory CD4 +T cells) could be induced to gen-
erate the resistance [24,26,46], we adopted a strategy using
total CD4 + T cell population to start our study withoutTable 2 Genes involved in cell cycle arrest
Profiles Genes of cell cycle arrest GenBank accession
Bup APBB2 NM_173075
Bup CDKN1A NM_078467 H
Bup & PdownBup DST NM_015548 H
Bup GAS2L3 NM_174942 Ho
Bup NAPSA NM_004851 H
Bup NOL3 NM_003946 Ho
Bup SESN2 NM_031459
Bup TCF4 NM_003199prior cell sorting before co-stimulations. This gave us the
chance to address the issue of which subset of CD4 +T
cells was generated to be responsible for the induced resist-
ance and led us to the first set of our findings, which shows
a homogenous cell population emerged from the co-
stimulation. These cells expressed three activation markers
(CD25, CD69 and CD45RO) at high levels at the same
time. Although the expression of these classical activation
markers may not ultimately account for the induced resist-
ance, they served well as indicators for the highly activated
population and, more relevant to the following analysis,
the homogeneity of the induced cells gave us the confi-
dence for the subsequent whole-genome wide search for
the “key regulatory genes” and the “core marker genes” in
the status switch to resistance.
Apart from the above novel findings in defining the cell
population emerged during the reversal of susceptibility,
the present study is the first whole-genome-wide analysis
for the genes that account for the induced resistance. Once
again, the system allowed us to pin down the potential per-
missive and resistant genes since susceptible “P” and the re-
sistant “B” cells are polarized at the two extremities of the
“permissive spectrum”. As a result, the 1,345 genes in the 6
specific profiles for the “B” and “P” cells could be truly the
representatives accounting for the intrinsic susceptibility to
HIV-1 infection and its induced reversal in the target cells.
This simple dichotomy classification further allowed us to
analyze the differentially expressed genes for their gene
ontology and co-expression with ease and confidence.
We have not included the popular pathway and tran-
script factor analysis in this initial genome-wide search
but, by focusing on the gene categories and co-expression,
managed to identify the major cellular processes involved
the reversed susceptibility in the major HIV-1 target cells.
Prominently, these include actin cytoskeleton system, pro-
tein degradation and cell cycle arrest. First, several lines of
evidence highlighted that actin cytoskeleton were regarded
as a barrier and the hijack of actin cytoskeleton facilitates
entry of HIV into its target cells [47,48]. In our study,Description
Homo sapiens amyloid beta (A4) precursor protein-binding, family B,
member 2 (Fe65-like) (APBB2), mRNA [NM_173075]
omo sapiens cyclin-dependent kinase inhibitor 1A (p21, Cip1) (CDKN1A),
transcript variant 2, mRNA [NM_078467]
omo sapiens dystonin (DST), transcript variant 1eA, mRNA [NM_015548]
mo sapiens growth arrest-specific 2 like 3 (GAS2L3), mRNA [NM_174942]
omo sapiens napsin A aspartic peptidase (NAPSA), mRNA [NM_004851]
mo sapiens nucleolar protein 3 (apoptosis repressor with CARD domain)
(NOL3), mRNA [NM_003946]
Homo sapiens sestrin 2 (SESN2), mRNA [NM_031459]
Homo sapiens transcription factor 4 (TCF4), mRNA [NM_003199]
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MYH10 and PAK2) were found up-regulated in the resist-
ant “B” cells (“Bup” profile in Figure 8A). These genes me-
diate assembly and contraction of actin and actomyosin
and formation of tight junctions. Whether they formed a
barrier against HIV-1 infection warrant further functional
verifications. To the contrary, genes associated with actin
polymerization (FN1 and ITGAX, Figure 8A), which have
been shown to promote viral binding and entry [48] and is
also necessary in chemotaxis and cytokinesis [49] was
sharply down regulated in the “B” cells. Given that chemo-
taxis may actually serve to fuel the infection response by
recruiting susceptible, activated CD4 + T cells to the virus,
ultimately aiding viral dissemination [49], we therefore hy-
pothesized that co-stimulation could also block the tracks
for HIV-1 release and dissemination by reducing actin
polymerization and chemotactic response.
Second, genes involved in ubiquitin-dependent degrad-
ation by the proteasome (WNT3, FZD1, FZD2, FZD3,
FBXW11, RAD23B, DBAHV2, HLPA4L, IRAK3, IL1RAP,
PROC and PROS1), which is the third step of endoplasmic
reticulum associated protein degradation, were also pre-
dominantly in “B” cells (Figure 8B). This is consistent with
previously report that the ubiquitin-proteasome was nega-
tively associated with HIV-1 replication by acting to des-
troy incoming viral complexes at the early steps [50,51].
We also found that ATPVOA4 and IGF2R, which are
important for lysosome-mediated degradation of endo-
cytosed proteins [52,53], were up-regulated in “B” cells
(Figure 8B). Therefore, co-stimulation could enhance the
cellular defense to HIV-1 infection by up-regulating these
lysosome- and proteasome-related genes [54].
Third, it is also noticeable that 8 unique genes (Table 2)
involved in cell cycle arrest were up-regulated in “B”
cells. Apparently, these genes may have helped for the
co-stimulated cells to reach the highly proliferative sta-
tus. However, their role in HIV-1/AIDS infection and
disease progression need further detailed studies since
modifications to the cell cycles was observed in both
long-term non-progressors (LTNPs) and progressive pa-
tients [55,56]. Anyhow, this line of evidence reflects that
host target cells may have intrinsic mechanisms, which,
when activated, would halt viral infection at the specific
point of the cell cycle.
The other two major cellular programs which were
profoundly influenced by the co-stimulation were me-
tabolism and apoptosis (Figure 4B). This seems incon-
sistent with previous studies showing that (a) numerous
metabolism-associated genes were down-regulated in
LTNPs [55] and (b) apoptosis is widely accepted as a
mechanism for T cell depletion in vitro and in vivo
[3,57,58]. Further 5 genes (CA2, MED28, PLOD2, SLC2A3
and TMTC1), which were up-regulated as probably
resistant genes in our “B” cells, were proposed as “hostdependent factors (HDF)” in recent small-interfering
RNA-knockdown screens [1-4,20]. More surprisingly per-
haps, in our set of potentially resistant genes, we did not
find any overlap with those reported to be associated with
LTNPs [55], viral latency [59,60], or even the “resistance
genes” identified by virus-host interaction network ana-
lysis using public data sets [61] (data not shown). How-
ever, these apparent discrepancies do not necessarily
discredit our studies but, to the contrary, may favorably
underscore the uniqueness and importance of the highly
controlled experimental system we adopted and call for
further studies down the line.
Finally, we chose to examine the expression of CCR5
and CXCR4, the 2 major HIV-1 co-receptors, on the cell
surface by FACS analysis as the first part of our ongoing
efforts to verify our array data and analysis. To our satis-
faction, their expression in this set of experiments and
our previous screening [40] consistently corroborated
our bioinformatics analysis and helped in explaining the
fact that the induced resistance by the co-stimulation is
a CCR5-dependent phenomenon [24,44,45]. Obviously,
large-scale validation and functional studies at both
mRNA and protein levels are needed to corroborate the
role of the key regulatory genes (e.g., ITGAX, VEGFA,
FN1, CCND1, CA12, LAMB3, MYL9, etc.) and their path-
ways as the major determinants for the induced resistance.
We hope the present study serves as a fresh call for a
renewed interest in the experimental system as a useful
model for the search of novel host resistant factors.
Conclusions
In summary, we replicated a simple yet powerful cellular
system with CD3/CD28 co-stimulation and confirmed
its usefulness in studying the induced resistance to HIV-
1 in CD4 + T cells. This initial microarray study, al-
though still descriptive and correlative in nature, allowed
us a chance to glean valuable new insights into this
phenomenon. Based on the overall expression patterns
and apparent signatures of the differentially expressed
genes, we managed to pin down 245 (101 potentially
permissive and 144 potentially resistant) significant func-
tional genes and 137 (84 potentially permissive and 53
potentially resistant) “key regulatory” genes involved in
the reversal of target cell susceptibility to HIV-1 infec-
tion. Moreover, we showed that this system has the
potential as a rich source for the search of novel genes
accounting for the intrinsic susceptibility to HIV-1 and
its reversal in the major target cells. We hope our find-
ings will stimulate renewed interest in investigating the
mechanisms underlying this phenomenon. We surmise
that future studies of this kind will help in furthering
our understanding of HIV-1 infection, which may ultim-
ately then lead to the development of novel biomarkers
and therapeutics.
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Additional file 1: Figure S1. Comparative CFSE staining among “R”, “P”
and “B” cells. Cells of “R” were stained with CFSE and cells of “P” and “B”
were stained with CFSE on day 3 and day 6. Significant T cell
proliferation was observed during the culture period.
Additional file 2: Figure S2. Comparative Ki67 staining among “R”, “P”
and “B” cells. Cells of “R” were stained with anti-Ki67 and cells of “P” and
“B” were stained with anti-Ki67 on day 3 and day 6 and it also showed
significant T cell proliferation during the culture period. Red line: isotype
control; green line: Ki67.
Additional file 3: Table S1. Differentially expressed genes.
Additional file 4: Table S2. Profiles of differentially expressed genes.
Additional file 5: Table S3. Gene ontologies of the differentially
expressed genes in “P” and “B” cells.
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Additional file 7: Table S5. Interactions between HIV-1 proteins and
significant functional genes.
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